Literature DB >> 7512567

Characterization of a 60-kilodalton substrate of the insulin receptor kinase.

Y Hosomi1, K Shii, W Ogawa, H Matsuba, M Yoshida, Y Okada, K Yokono, M Kasuga, S Baba, R A Roth.   

Abstract

A 60-kDa tyrosine-phosphorylated protein has been observed after insulin treatment of cells in immunoprecipitations of the GTPase-activating protein of Ras (called GAP) as well as the phosphatidylinositol 3-kinase. In the present studies, these two 60-kDa proteins have been shown to differ by limited proteolytic digestions as well as by immunoprecipitation with a monoclonal antibody. This monoclonal antibody was also utilized to show that the 60-kDa GAP-associated protein was rapidly phosphorylated in intact cells after insulin stimulation and to associate with GAP only after insulin treatment of the cells. In addition, the 60-kDa protein was found to be phosphorylated in vitro by the insulin receptor. Finally, the 60-kDa protein immunoprecipitated by this antibody was found not to react with a polyclonal antibody directed against a 62-kDa tyrosine-phosphorylated GAP-associated protein previously observed in src-transformed cells. These studies indicate that insulin stimulates the tyrosine phosphorylation of at least two distinct 60-kDa proteins, one that becomes associated with GAP and appears to be a direct substrate of the insulin receptor kinase and another that associates with the phosphatidylinositol 3-kinase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512567

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.

Authors:  J C Brüning; J Winnay; B Cheatham; C R Kahn
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency.

Authors:  B F Hansen; G M Danielsen; K Drejer; A R Sørensen; F C Wiberg; H H Klein; A G Lundemose
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

Review 4.  Role of binding proteins to IRS-1 in insulin signalling.

Authors:  W Ogawa; T Matozaki; M Kasuga
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap.

Authors:  P van der Geer; M Henkemeyer; T Jacks; T Pawson
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

Review 6.  Molecular mechanisms for the control of translation by insulin.

Authors:  C G Proud; R M Denton
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

7.  Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function.

Authors:  F Liu; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase.

Authors:  S Pons; T Asano; E Glasheen; M Miralpeix; Y Zhang; T L Fisher; M G Myers; X J Sun; M F White
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

9.  The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

Authors:  K Neet; T Hunter
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

10.  Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration.

Authors:  T Noguchi; T Matozaki; K Inagaki; M Tsuda; K Fukunaga; Y Kitamura; T Kitamura; K Shii; Y Yamanashi; M Kasuga
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.